Novak Alfred J has filed 5 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 42913 shares of Pasithea Therapeutics Corp. ($KTTA) on October 24, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 24, 2025 | Pasithea Therapeutics Corp. | $KTTA | Novak Alfred J | Director | A | Stock Option (right to buy) | 42913 | $0.00 | 42,913.0000 | 7,443,577 | 9999.99% | 0.58% |
| June 12, 2024 | Pasithea Therapeutics Corp. | $KTTA | Novak Alfred J | Director | A | Common Stock | 750 | $5.61 | 750.0000 | 1,042,479 | 9999.99% | 0.07% |
| June 13, 2024 | Pasithea Therapeutics Corp. | $KTTA | Novak Alfred J | Director | A | Common Stock | 2750 | $5.62 | 3,500.0000 | 1,042,479 | 366.67% | 0.26% |
| March 1, 2024 | Pasithea Therapeutics Corp. | $KTTA | Novak Alfred J | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 1,226,600 | 9999.99% | 0.41% |
| March 1, 2024 | Pasithea Therapeutics Corp. | $KTTA | Novak Alfred J | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 1,226,600 | 9999.99% | 0.41% |